When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Urticária e angioedema

最后审阅: 13 Feb 2025
最后更新: 04 Dec 2024

小结

Definition

History and exam

Key diagnostic factors

  • lesões edematosas eritematosas
  • prurido
  • resolução em 24 horas
  • inchaço da face, língua ou lábios
Full details

Other diagnostic factors

  • lesões esbranquiçadas
  • estridor
Full details

Risk factors

  • história familiar positiva
  • sexo feminino
  • exposição a medicamento desencadeante
  • exposição a alimento desencadeante
  • infecção viral recente
  • ferroada ou picada de inseto recente
Full details

Diagnostic tests

1st tests to order

  • Hemograma completo com diferencial
  • velocidade de hemossedimentação (VHS)
  • proteína C-reativa
  • nível de C4
Full details

Tests to consider

  • hormônio estimulante da tireoide (TSH)
  • fatores antinucleares (FANs)
  • teste alérgico cutâneo por puntura ("prick test")
  • dieta para evitar alérgenos
  • triptase sérica
  • biópsia de pele
  • nível de inibidor de C1 esterase
  • função do inibidor de C1 esterase
  • níveis de C1q
  • IgE específica para alérgeno suspeito
Full details

Treatment algorithm

ACUTE

urticária aguda ± angioedema

angioedema hereditário

ONGOING

urticária crônica ± angioedema

angioedema sem urticária induzido por medicamento

angioedema idiopático sem urticária

angioedema hereditário

Contributors

Authors

Jonathan Bernstein, MD

Professor of Medicine

Department of Internal Medicine

Division of Immunology/Allergy Section

University of Cincinnati

Cincinnati

OH

Disclosures

JB is a consultant, contracted researcher, and speaker for Sanofi-Regeneron, AstraZeneca, Novartis/Regeneron, Genentech, Shire/Takeda, CSL Behring, Pharming and Biocryst. He is also a consultant and contracted researcher for Amgen, Allakos, Celldex, Kalvista, Biomarin and IONIS. JB is a consultant for Escient, Ono and Pharvaris, he is on the board of directors for AAAAI, and is a member of the Joint Task Force practice parameter. JB has spoken on this topic at National, International and Regional/Local Educational meetings. JB is an author of abstracts and manuscripts related to these topics and is an author of a number of references cited in this topic.

Acknowledgements

Dr Jonathan Bernstein would like to gratefully acknowledge Dr S. Shahzad Mustafa and Dr Stephen Dreskin, previous contributors to this topic.

გაფრთხილება:

SM is on the speakers' panel and advisory board for Genentech. SD declares that he has no competing interests.

რეცენზენტები

Frances Humphreys, MB BS, FRCP

Consultant Dermatologist

Warwick Hospital

Honorary Associate Professor

University of Warwick

Warwick Hospital

Warwick

UK

გაფრთხილება:

FH has attended educational events organised and funded by Almrall and Schering Plough; has received a speaker's fee from Steibel, Leo, and Schering Plough; and is an author of references cited in this topic.

Alexander M. Marsland, MRCP

Consultant in Dermatology

University Hospital of South Manchester

Manchester

UK

გაფრთხილება:

None declared.

Luz Fonacier, MD

Head of Allergy and Training Program Director

Winthrop University Hospital

Associate Professor of Clinical Medicine

SUNY at Stony Brook

Stony Brook

NY

გაფრთხილება:

LF declares that she has no competing interests.

  • Urticária e angioedema images
  • დიფერენციული დიაგნოზები

    • Anafilaxia
    • Dermografismo
    • Dermatite atópica
    მეტი დიფერენციული დიაგნოზები
  • გაიდლაინები

    • The international WAO/EAACI guideline for the management of hereditary angioedema: the 2021 revision and update​
    • Guidelines for the management of people with chronic urticaria
    მეტი გაიდლაინები
  • padlock-lockedშედით სისტემაში ან გამოიწერეთ BMJ Best Practice

ამ მასალის გამოყენება ექვემდებარება ჩვენს განცხადებას